8ZHW | pdb_00008zhw

Structure of Mokola lyssavirus glycoprotein in post-fusion state


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free: 
    0.288 (Depositor), 0.292 (DCC) 
  • R-Value Work: 
    0.246 (Depositor), 0.247 (DCC) 
  • R-Value Observed: 
    0.248 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Structures of two lyssavirus glycoproteins trapped in pre- and post-fusion states and the implications on the spatial-temporal conformational transition along with pH-decrease.

Yang, F.Lin, S.Yuan, X.Shu, S.Yu, Y.Yang, J.Ye, F.Chen, Z.He, B.Li, J.Zhao, Q.Ye, H.Cao, Y.Lu, G.

(2025) PLoS Pathog 21: e1012923-e1012923

  • DOI: https://doi.org/10.1371/journal.ppat.1012923
  • Primary Citation of Related Structures:  
    8ZHW, 8ZHZ

  • PubMed Abstract: 

    Lyssavirus glycoprotein plays a crucial role in mediating virus entry and serves as the major target for neutralizing antibodies. During membrane fusion, the lyssavirus glycoprotein undergoes a series of low-pH-induced conformational transitions. Here, we report the structures of Ikoma lyssavirus and Mokola lyssavirus glycoproteins, with which we believe that we have trapped the proteins in pre-fusion and post-fusion states respectively. By analyzing the available lyssaviral glycoprotein structures, we present a sequential conformation-transition model, in which two structural elements in the glycoprotein undergo fine-modulated secondary structural transitions, changing the glycoprotein from a bended hairpin conformation to an extended linear conformation. In addition, such conformational change is further facilitated, as observed in our surface plasmon resonance assay, by the pH-regulated interactions between the membrane-proximal region and the pleckstrin homology and the fusion domains. The structural features elucidated in this study will facilitate the design of vaccines and anti-viral drugs against lyssaviruses.


  • Organizational Affiliation
    • Department of Emergency Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Glycoprotein
A, B, C
436Lyssavirus mokolaMutation(s): 0 
UniProt
Find proteins for P0C572 (Mokola virus)
Explore P0C572 
Go to UniProtKB:  P0C572
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0C572
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free:  0.288 (Depositor), 0.292 (DCC) 
  • R-Value Work:  0.246 (Depositor), 0.247 (DCC) 
  • R-Value Observed: 0.248 (Depositor) 
Space Group: P 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 104.235α = 90
b = 87.518β = 111.87
c = 111.189γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-2000data reduction
HKL-2000data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2025-02-05
    Type: Initial release
  • Version 1.1: 2025-08-20
    Changes: Database references